Bacterial vaginosis (BV) is treated with antibiotics, either taken by mouth or applied vaginally, and most cases clear within a week of starting treatment. The challenge isn’t the initial cure. It’s keeping BV from coming back: more than 50% of women relapse within three to six months, and rates climb as high as 69% within a year. Understanding your full range of options, from first-line antibiotics to newer strategies for preventing recurrence, makes a real difference in long-term outcomes.
What BV Is and Why It Happens
BV isn’t a traditional infection caused by a single invading organism. It’s a shift in the balance of bacteria that naturally live in the vagina. In a healthy vaginal environment, beneficial bacteria (primarily Lactobacillus species) keep the pH acidic, usually below 4.5. When those protective bacteria decline and other organisms overgrow, the pH rises and BV develops.
The most recognizable symptoms are a thin, white or grayish discharge and a fishy odor, which often becomes more noticeable after sex. Some women have no symptoms at all and only learn they have BV through a routine exam. Diagnosis typically involves checking vaginal pH (above 4.5 in BV), looking for characteristic “clue cells” under a microscope, and performing a whiff test where a chemical solution is added to a sample to see if it releases a fishy smell. Meeting three of these four clinical markers confirms the diagnosis.
Standard Antibiotic Treatment
The CDC recommends three first-line options, all with similar effectiveness. The most common is oral metronidazole, taken twice daily for seven days. For women who prefer to avoid oral antibiotics or experience side effects like nausea, there are two vaginal options: metronidazole gel applied once daily for five days, or clindamycin cream applied at bedtime for seven days. All three regimens work well for the initial episode, and the choice often comes down to personal preference and how your body handles each one.
A newer option is secnidazole, the only FDA-approved single-dose oral treatment for BV. It comes as granules mixed into applesauce, and you take it just once. The convenience is appealing, though cure rates at 21 to 30 days range from 53% to 68%, which is somewhat lower than the full seven-day courses. For women who struggle with completing a week-long regimen, that tradeoff may be worth it.
During treatment with metronidazole, you should avoid alcohol entirely, as the combination can cause severe nausea and vomiting. Vaginal creams and gels can also weaken latex condoms, so use alternative protection or abstain during the treatment window.
Why BV Keeps Coming Back
Recurrence is the single most frustrating aspect of BV. Even after successful antibiotic treatment, the underlying vaginal environment may not fully recover its protective Lactobacillus population. Without that bacterial shield, the conditions that caused BV in the first place can easily return.
A landmark 2024 trial published in the New England Journal of Medicine revealed something that changes how we think about recurrence: male sexual partners carry the same BV-associated bacteria on the penis, and they pass it back during sex. The trial was actually stopped early by its safety board because the results were so clear. Among couples where only the woman was treated, 63% experienced recurrence within 12 weeks. When the male partner also received antibiotics (both oral and topical), that rate dropped to 35%. That’s a reduction of about 2.6 fewer recurrences per year. If you have a regular male partner and keep getting BV after treatment, this finding is worth discussing with your provider.
Options for Recurrent BV
For women dealing with repeated episodes, several strategies go beyond the standard one-and-done antibiotic course.
Boric acid vaginal suppositories have gained significant traction as a treatment for recurrent BV. A typical protocol involves 600 mg inserted at bedtime for 14 consecutive nights. In a recent clinical study, this regimen achieved microbiological cure in 88.5% of participants, with clue cells dropping from 68% to 8% and vaginal odor falling from 92% to under 2%. Side effects were mild: only about 8% of women experienced a temporary burning sensation in the first few days, and it resolved on its own. Boric acid is not taken orally and is toxic if swallowed, so it’s strictly a vaginal treatment.
Probiotic therapy is another approach with growing evidence behind it. A randomized trial tested a vaginal probiotic containing Lactobacillus crispatus, applied after completing standard metronidazole treatment. Women used it vaginally for 11 weeks, and at 12 weeks, the beneficial bacteria were detected in nearly 80% of participants. The probiotic group had significantly fewer recurrences than the placebo group. By week 24, about half still had detectable colonization, suggesting the protective bacteria can take hold but may need ongoing support. This specific product (Lactin-V) is a pharmaceutical-grade biotherapeutic, not the same as over-the-counter probiotic supplements, which have far less evidence behind them.
BV During Pregnancy
BV carries specific risks during pregnancy. The condition is linked to higher rates of preterm delivery, particularly when it persists or goes untreated. The connection runs through inflammation: BV-associated bacteria can trigger infection of the membranes surrounding the baby, which is a leading cause of preterm labor. Research shows that women with BV in early pregnancy have significantly higher preterm delivery rates compared to women with normal vaginal flora.
Interestingly, BV often improves on its own during pregnancy, but waiting isn’t always safe. Whether antibiotic treatment in early pregnancy actually prevents preterm birth remains debated. Some studies show a protective effect, while several large randomized trials have found no benefit. Pregnant women diagnosed with BV are still generally treated, both for symptom relief and to reduce infection risk, but the evidence on preventing preterm outcomes specifically is mixed.
Habits That Protect Your Vaginal Flora
Certain everyday practices directly influence whether BV develops or returns. Douching is the most well-established risk factor you can control. Research shows that douching solutions, regardless of their pH, damage vaginal health. Acidic douches (like vinegar) harm beneficial Lactobacillus bacteria, while alkaline douches (like baking soda) damage vaginal epithelial cells and trigger inflammation. Both outcomes leave the vagina more vulnerable to BV and urinary tract infections. The vagina is self-cleaning, and douching disrupts the very system that keeps it balanced.
Other practical steps that support vaginal health include using unscented soaps on external areas only, wearing breathable cotton underwear, and changing out of wet swimwear or workout clothes promptly. Condom use during sex reduces the introduction of BV-associated bacteria, which is especially relevant if you have a new partner or multiple partners. Smoking is also independently linked to BV, likely because it reduces Lactobacillus populations in the vagina, though the exact mechanism isn’t fully understood.
If you’re someone who gets BV repeatedly, the combination approach tends to work best: treat the active episode with antibiotics, consider concurrent partner treatment if applicable, follow up with a probiotic or boric acid maintenance regimen, and eliminate douching and other disruptive practices. No single intervention solves recurrent BV for everyone, but layering these strategies significantly improves the odds of staying clear.